Leadership, Planning and Evaluation

领导、规划和评估-总结/摘要 CCSG高级领导层包括德克萨斯大学医学博士安德森癌症中心主席和 首席研究员Peter Pisters博士;转化研究副总裁兼副主任Robert博士 巴斯特;首席科学官临时，朱利奥Draetta博士;副主任，癌症预防和人口 副主任，临床和跨学科研究，博士乔治威尔丁; 临床研究管理局副主任，Aman Buzdar博士;癌症健康副主任 差异和社区外展，洛娜麦克尼尔博士;副主任，职业发展，米歇尔博士 巴顿和副主任，CCSG管理，艾伦麦克莱兰博士。作为MD安德森的总裁， Pisters对机构的各个方面都有权威，为所有临床， 研究、教育和预防活动。CCSG执行委员会包括CCSG所有高级 领导人，并由Pisters博士担任主席，确保整个机构领导结构之间的一致性 和CCSG的。 MD安德森使用几种外部和内部审查机制进行规划和评估， 改善癌症中心。CCSG提供的资金支持外部咨询委员会（EAB），由以下人员组成： 34位杰出的科学顾问每年开会，向CCSG高级领导层Pisters博士提供建议， CCSG项目负责人和CCSG共享资源主管。EAB审查研究计划并分享 资源，以1）评估他们的生产力，卓越，并与机构目标的一致性; 2）确定差距， 科学专业知识或能力，并提出缩小这些差距的选择; 3）考虑新的计划或 重组现有的计划; 4）协助招聘优秀的教师机构;和5）评估 基础科学家、转化/临床科学家和基于人群的 调查人员，建议采取行动，以加强这三个群体之间的互动。内部机制 审查研究项目、共享资源和研究规划，包括项目务虚会;临床 研究方案和概念审查;项目负责人和共享资源主任向 秘书长协调小组执行委员会和其他领导小组，包括所有人的主席社区会议 部门主席;以及中心领导与项目负责人的会议。调查、焦点小组和用户 委员会还审查了本赠款期间的每一项共享资源。作为更新的前奏 根据MD安德森的战略计划，几个作战优先任务小组负责定义和 实施对MD安德森使命具有直接重要性的具体近期行动。虽然 业务优先事项并不代表战略计划，对这些优先事项的关注已经奠定了基础 在未来一年，将根据这一点制定战略计划。

LEADERSHIP, PLANNING, AND EVALUATION – SUMMARY/ABSTRACT The CCSG senior leadership comprises The University of Texas MD Anderson Cancer Center president and principal investigator, Dr. Peter Pisters; vice president for Translational Research and deputy director, Dr. Robert Bast; chief scientific officer ad interim, Dr. Giulio Draetta; associate director, Cancer Prevention and Population Sciences, Dr. Ernie Hawk; associate director, Clinical and Interdisciplinary Research, Dr. George Wilding; associate director, Clinical Research Administration, Dr. Aman Buzdar; associate director, Cancer Health Disparities and Community Outreach, Dr. Lorna McNeill; associate director, Career Enhancement, Dr. Michelle Barton; and associate director, CCSG Administration, Dr. Alan McClelland. As president of MD Anderson, Dr. Pisters has authority over all aspects of the institution, providing vision and ultimate oversight for all clinical, research, education, and prevention activities. The CCSG Executive Committee includes all senior CCSG leaders and is chaired by Dr. Pisters, ensuring alignment between the overall institutional leadership structure and that of the CCSG. MD Anderson uses several external and internal review mechanisms for planning and evaluation to develop and improve the cancer center. Funding from the CCSG supports an External Advisory Board (EAB), consisting of 34 distinguished scientific advisors that meets annually to provide advice to Dr. Pisters, CCSG senior leadership, CCSG program leaders, and CCSG shared resource directors. The EAB reviews research programs and shared resources to 1) evaluate their productivity, excellence, and alignment with institutional goals; 2) identify gaps in scientific expertise or capabilities and suggest options for closing these gaps; 3) consider new programs or restructuring of existing programs; 4) assist in recruiting outstanding faculty to the institution; and 5) evaluate the extent of collaboration among basic scientists, translational/clinical scientists, and population-based investigators, recommending actions to enhance interactivity among these 3 groups. Mechanisms for internal review of research programs, shared resources, and research planning include program retreats; clinical research protocol and concept reviews; presentations by program leaders and shared resource directors to the CCSG Executive Committee and to other leadership groups, including the Community of Chairs meeting of all department chairs; and meetings of center leadership with program leaders. Surveys, focus groups, and user committees have also reviewed each shared resource during the current grant period. As a prelude to updating MD Anderson's Strategic Plan, several Operational Priority task forces have been charged with defining and implementing specific near-term actions of immediate importance to the MD Anderson mission. Although the operational priorities do not represent a strategic plan, the focus on these priorities has established a foundation on which the strategic plan will be developed over the coming year.